Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco P Schena

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Transplantation|April 23, 2009
Review of symposium. Sirolimus in kidney transplantationFrancesco P Schena
Internal and Emergency Medicine|October 20, 2011
Management of patients with chronic kidney diseaseFrancesco P Schena
Journal of the American Society of Nephrology : JASN|June 7, 2005
Pathogenetic mechanisms of diabetic nephropathyFrancesco P Schena, Loreto Gesualdo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 26, 2007
Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitorsJosep M Campistol, Francesco P Schena
Clinical Science (London, England : 1979)|April 18, 2015
microRNAs in glomerular diseases from pathophysiology to potential treatment targetFrancesco P Schena, Fabio Sallustio, Grazia Serino
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 31, 2003
An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticismGiovanni F M Strippoli, Carlo Manno, Francesco P Schena
Journal of Nephrology|February 18, 2016
Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?Erika Nerini, Fulvio Bruno, Franco Citterio, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
The number, quality, and coverage of randomized controlled trials in nephrologyGiovanni F M Strippoli, Jonathan C Craig, Francesco P Schena
Journal of Nephrology|December 1, 2006
Evidence for optimal hemoglobin targets in chronic kidney diseaseSankar D Navaneethan, Carmen Bonifati, Francesco P Schena, et al.
Clinical Kidney Journal|January 8, 2024
Kidney and urine cell transcriptomics in IgA nephropathy and lupus nephritis: a narrative reviewFrancesco P Schena, Samantha Chiurlia, Daniela I Abbrescia, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Transplantation|April 23, 2009
Review of symposium. Sirolimus in kidney transplantationFrancesco P Schena
Internal and Emergency Medicine|October 20, 2011
Management of patients with chronic kidney diseaseFrancesco P Schena
Journal of the American Society of Nephrology : JASN|June 7, 2005
Pathogenetic mechanisms of diabetic nephropathyFrancesco P Schena, Loreto Gesualdo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 26, 2007
Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitorsJosep M Campistol, Francesco P Schena
Clinical Science (London, England : 1979)|April 18, 2015
microRNAs in glomerular diseases from pathophysiology to potential treatment targetFrancesco P Schena, Fabio Sallustio, Grazia Serino
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 31, 2003
An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticismGiovanni F M Strippoli, Carlo Manno, Francesco P Schena
Journal of Nephrology|February 18, 2016
Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?Erika Nerini, Fulvio Bruno, Franco Citterio, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
The number, quality, and coverage of randomized controlled trials in nephrologyGiovanni F M Strippoli, Jonathan C Craig, Francesco P Schena
Journal of Nephrology|December 1, 2006
Evidence for optimal hemoglobin targets in chronic kidney diseaseSankar D Navaneethan, Carmen Bonifati, Francesco P Schena, et al.
Clinical Kidney Journal|January 8, 2024
Kidney and urine cell transcriptomics in IgA nephropathy and lupus nephritis: a narrative reviewFrancesco P Schena, Samantha Chiurlia, Daniela I Abbrescia, et al.
Pageof 8